Skip to main content
OpenTrials
Completed

NCT Number: NCT00992264

'Questions About Quitting' Smoking Cessation Trial

The current study tested the effectiveness of four potentially important tailoring factors (decisional framework, self-efficacy, navigation autonomy, and proactive outreach) in the context of an online motivational intervention for smoking cessation. A fifth factor was originally planned by dropped during intervention development due to confounds with the other planned factors. Information learned from this study will inform how to best design an online interventions for smoking cessation. Participants were recruited from a large, regional U.S. health plan. Using a full factorial design to screen for important main effects and 2-way interactions, participants were randomized to receive one of 16 different experimental factor combinations and followed for one year to assess program impact on smokers' use of empirically-validated cessation treatment and abstinence.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Group Health Research Institute

Seattle, Washington, 98101, United States

About this study

The current study is a factorial screening experiment, consistent with the Multiphase Optimization Strategy. Participants were randomly assigned to one of 16 different combinations of the 4 experimental factors. Each factor was explored on 2 contrasting levels. Each contrasting factor level was then compared to the other, resulting in 4 analytic arms. Within each arm, all participants (n = 1865) were analyzed to determine the relative effect of each contrasting factor level on the primary and secondary outcomes of interest.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Member of Group Health Cooperative
  • Currently Smoking at Least 5 Cigarettes/Day
  • Access to Email and the Internet
  • Read and Write English
  • 18 years or older
  • Not currently receiving tobacco cessation treatment
  • Capable of participating in online and phone surveys

Exclusion criteria

  • Persons will be excluded if they do not meet above criteria

Treatment and study plan

Message Tone

Behavioral

All participants receive an tailored, online smoking cessation program. Participants in this intervention group either receive content written in a prescriptive tone or a motivational tone.

Navigation

Behavioral

Persons in this arm either have their ability to navigate the site dictated for them based on their readiness to quit smoking or they are able to freely navigate through the website.

Proactive outreach

Behavioral

Persons receive periodic, proactively delivered email reminders to visit the intervention website.

Testimonials

Behavioral

People receive a personally-tailored testimonial as part of their online smoking cessation program.

Primary outcomes

  1. Smoking Abstinence

    Time frame: 12 months

    7 day point prevalent abstinence

  2. Treatment Utilization for Smoking Cessation

    Time frame: 12 months

    confirmed use of pharmacotherapy or enrollment in health plan-sponsored counseling program

Sponsors and collaborators

Lead sponsor

Kaiser Permanente

Other

Collaborators

  • University of Michigan

Registry information

Official study title

Optimizing an Online Motivational Tobacco Cessation Program

Acronym: Q2

Important dates

Study start
2010
Primary completion
2012
Study completion
2013
First posted
Oct 9, 2009
Registry last updated
Oct 13, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.